nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—Pain localised—Docetaxel—head and neck cancer	0.0668	0.0712	CcSEcCtD
Sotalol—Atrophy—Hydroxyurea—head and neck cancer	0.0455	0.0484	CcSEcCtD
Sotalol—Isoprenaline—MAPK1—head and neck cancer	0.0339	0.56	CrCbGaD
Sotalol—Colitis ischaemic—Docetaxel—head and neck cancer	0.0262	0.0279	CcSEcCtD
Sotalol—Sudden death—Fluorouracil—head and neck cancer	0.0209	0.0222	CcSEcCtD
Sotalol—Ibuprofen—BCL2—head and neck cancer	0.0157	0.259	CrCbGaD
Sotalol—Heartburn—Fluorouracil—head and neck cancer	0.0155	0.0165	CcSEcCtD
Sotalol—Photophobia—Vinblastine—head and neck cancer	0.0153	0.0163	CcSEcCtD
Sotalol—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.0132	0.0141	CcSEcCtD
Sotalol—Eye irritation—Fluorouracil—head and neck cancer	0.0125	0.0133	CcSEcCtD
Sotalol—Cerebrovascular accident—Vinblastine—head and neck cancer	0.012	0.0128	CcSEcCtD
Sotalol—Disorientation—Hydroxyurea—head and neck cancer	0.012	0.0128	CcSEcCtD
Sotalol—Heartburn—Docetaxel—head and neck cancer	0.0112	0.0119	CcSEcCtD
Sotalol—Throat sore—Docetaxel—head and neck cancer	0.0107	0.0114	CcSEcCtD
Sotalol—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.0106	0.0113	CcSEcCtD
Sotalol—Photophobia—Fluorouracil—head and neck cancer	0.01	0.0107	CcSEcCtD
Sotalol—Angina pectoris—Vinblastine—head and neck cancer	0.00994	0.0106	CcSEcCtD
Sotalol—Depression—Vinblastine—head and neck cancer	0.00907	0.00966	CcSEcCtD
Sotalol—Eye irritation—Docetaxel—head and neck cancer	0.00902	0.0096	CcSEcCtD
Sotalol—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00897	0.00955	CcSEcCtD
Sotalol—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00892	0.00949	CcSEcCtD
Sotalol—Myocardial infarction—Vinblastine—head and neck cancer	0.00892	0.00949	CcSEcCtD
Sotalol—Disorientation—Fluorouracil—head and neck cancer	0.00866	0.00922	CcSEcCtD
Sotalol—Agranulocytosis—Vinblastine—head and neck cancer	0.00849	0.00904	CcSEcCtD
Sotalol—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00847	0.00902	CcSEcCtD
Sotalol—Drowsiness—Hydroxyurea—head and neck cancer	0.0083	0.00883	CcSEcCtD
Sotalol—Amnesia—Fluorouracil—head and neck cancer	0.00825	0.00878	CcSEcCtD
Sotalol—Haemoglobin—Vinblastine—head and neck cancer	0.00821	0.00874	CcSEcCtD
Sotalol—Haemorrhage—Vinblastine—head and neck cancer	0.00817	0.00869	CcSEcCtD
Sotalol—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00813	0.00866	CcSEcCtD
Sotalol—Cardiac failure—Fluorouracil—head and neck cancer	0.00794	0.00845	CcSEcCtD
Sotalol—Lethargy—Fluorouracil—head and neck cancer	0.00791	0.00842	CcSEcCtD
Sotalol—Haemoglobin—Hydroxyurea—head and neck cancer	0.00749	0.00797	CcSEcCtD
Sotalol—Haemorrhage—Hydroxyurea—head and neck cancer	0.00745	0.00793	CcSEcCtD
Sotalol—Isoprenaline—CYP1A1—head and neck cancer	0.00728	0.12	CrCbGaD
Sotalol—Alopecia—Vinblastine—head and neck cancer	0.00722	0.00768	CcSEcCtD
Sotalol—Lightheadedness—Docetaxel—head and neck cancer	0.00689	0.00734	CcSEcCtD
Sotalol—Pulmonary oedema—Docetaxel—head and neck cancer	0.00686	0.0073	CcSEcCtD
Sotalol—Angiopathy—Hydroxyurea—head and neck cancer	0.00676	0.00719	CcSEcCtD
Sotalol—Eosinophilia—Fluorouracil—head and neck cancer	0.00663	0.00706	CcSEcCtD
Sotalol—Alopecia—Hydroxyurea—head and neck cancer	0.00658	0.00701	CcSEcCtD
Sotalol—Angina pectoris—Fluorouracil—head and neck cancer	0.00652	0.00694	CcSEcCtD
Sotalol—Vertigo—Vinblastine—head and neck cancer	0.00639	0.0068	CcSEcCtD
Sotalol—Leukopenia—Vinblastine—head and neck cancer	0.00636	0.00677	CcSEcCtD
Sotalol—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00622	0.00663	CcSEcCtD
Sotalol—Hypertension—Vinblastine—head and neck cancer	0.00614	0.00653	CcSEcCtD
Sotalol—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00611	0.00651	CcSEcCtD
Sotalol—Visual disturbance—Docetaxel—head and neck cancer	0.0059	0.00628	CcSEcCtD
Sotalol—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00589	0.00627	CcSEcCtD
Sotalol—Myocardial infarction—Fluorouracil—head and neck cancer	0.00585	0.00623	CcSEcCtD
Sotalol—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00585	0.00623	CcSEcCtD
Sotalol—Leukopenia—Hydroxyurea—head and neck cancer	0.0058	0.00618	CcSEcCtD
Sotalol—Cardiac failure—Docetaxel—head and neck cancer	0.00573	0.0061	CcSEcCtD
Sotalol—Lethargy—Docetaxel—head and neck cancer	0.00571	0.00608	CcSEcCtD
Sotalol—Thrombocytopenia—Vinblastine—head and neck cancer	0.00568	0.00605	CcSEcCtD
Sotalol—Pain in extremity—Docetaxel—head and neck cancer	0.00559	0.00595	CcSEcCtD
Sotalol—Agranulocytosis—Fluorouracil—head and neck cancer	0.00557	0.00593	CcSEcCtD
Sotalol—Haemoglobin—Fluorouracil—head and neck cancer	0.00539	0.00574	CcSEcCtD
Sotalol—Haemorrhage—Fluorouracil—head and neck cancer	0.00536	0.00571	CcSEcCtD
Sotalol—Oedema—Hydroxyurea—head and neck cancer	0.00529	0.00563	CcSEcCtD
Sotalol—Infection—Hydroxyurea—head and neck cancer	0.00526	0.0056	CcSEcCtD
Sotalol—Paraesthesia—Vinblastine—head and neck cancer	0.00521	0.00555	CcSEcCtD
Sotalol—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00518	0.00551	CcSEcCtD
Sotalol—Decreased appetite—Vinblastine—head and neck cancer	0.00504	0.00537	CcSEcCtD
Sotalol—Cramp muscle—Docetaxel—head and neck cancer	0.00504	0.00536	CcSEcCtD
Sotalol—Pain—Vinblastine—head and neck cancer	0.00496	0.00528	CcSEcCtD
Sotalol—Arrhythmia—Fluorouracil—head and neck cancer	0.00479	0.0051	CcSEcCtD
Sotalol—Bronchospasm—Docetaxel—head and neck cancer	0.00476	0.00506	CcSEcCtD
Sotalol—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00474	0.00505	CcSEcCtD
Sotalol—Alopecia—Fluorouracil—head and neck cancer	0.00474	0.00504	CcSEcCtD
Sotalol—Dyspnoea—Hydroxyurea—head and neck cancer	0.00472	0.00502	CcSEcCtD
Sotalol—Angina pectoris—Docetaxel—head and neck cancer	0.00471	0.00501	CcSEcCtD
Sotalol—Somnolence—Hydroxyurea—head and neck cancer	0.0047	0.00501	CcSEcCtD
Sotalol—Dyspepsia—Hydroxyurea—head and neck cancer	0.00466	0.00496	CcSEcCtD
Sotalol—Decreased appetite—Hydroxyurea—head and neck cancer	0.0046	0.0049	CcSEcCtD
Sotalol—Abdominal pain—Vinblastine—head and neck cancer	0.00459	0.00488	CcSEcCtD
Sotalol—Fatigue—Hydroxyurea—head and neck cancer	0.00456	0.00486	CcSEcCtD
Sotalol—Pain—Hydroxyurea—head and neck cancer	0.00452	0.00482	CcSEcCtD
Sotalol—Vision blurred—Fluorouracil—head and neck cancer	0.0044	0.00468	CcSEcCtD
Sotalol—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00425	0.00452	CcSEcCtD
Sotalol—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00423	0.0045	CcSEcCtD
Sotalol—Myocardial infarction—Docetaxel—head and neck cancer	0.00423	0.0045	CcSEcCtD
Sotalol—Body temperature increased—Hydroxyurea—head and neck cancer	0.00418	0.00445	CcSEcCtD
Sotalol—Leukopenia—Fluorouracil—head and neck cancer	0.00418	0.00445	CcSEcCtD
Sotalol—Asthenia—Vinblastine—head and neck cancer	0.00416	0.00443	CcSEcCtD
Sotalol—Agranulocytosis—Docetaxel—head and neck cancer	0.00402	0.00428	CcSEcCtD
Sotalol—Myalgia—Fluorouracil—head and neck cancer	0.00397	0.00423	CcSEcCtD
Sotalol—Chest pain—Fluorouracil—head and neck cancer	0.00397	0.00423	CcSEcCtD
Sotalol—Diarrhoea—Vinblastine—head and neck cancer	0.00397	0.00423	CcSEcCtD
Sotalol—Haemoglobin—Docetaxel—head and neck cancer	0.00389	0.00414	CcSEcCtD
Sotalol—Haemorrhage—Docetaxel—head and neck cancer	0.00387	0.00412	CcSEcCtD
Sotalol—Dizziness—Vinblastine—head and neck cancer	0.00384	0.00408	CcSEcCtD
Sotalol—Oedema—Fluorouracil—head and neck cancer	0.00381	0.00405	CcSEcCtD
Sotalol—Asthenia—Hydroxyurea—head and neck cancer	0.0038	0.00404	CcSEcCtD
Sotalol—Infection—Fluorouracil—head and neck cancer	0.00378	0.00403	CcSEcCtD
Sotalol—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00373	0.00397	CcSEcCtD
Sotalol—Visual impairment—Docetaxel—head and neck cancer	0.00373	0.00397	CcSEcCtD
Sotalol—Vomiting—Vinblastine—head and neck cancer	0.00369	0.00393	CcSEcCtD
Sotalol—Ibuprofen—PTGS2—head and neck cancer	0.00368	0.0607	CrCbGaD
Sotalol—Headache—Vinblastine—head and neck cancer	0.00363	0.00387	CcSEcCtD
Sotalol—Diarrhoea—Hydroxyurea—head and neck cancer	0.00362	0.00385	CcSEcCtD
Sotalol—Hypotension—Fluorouracil—head and neck cancer	0.00356	0.00379	CcSEcCtD
Sotalol—Angiopathy—Docetaxel—head and neck cancer	0.00351	0.00374	CcSEcCtD
Sotalol—Dizziness—Hydroxyurea—head and neck cancer	0.0035	0.00372	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00347	0.00369	CcSEcCtD
Sotalol—Arrhythmia—Docetaxel—head and neck cancer	0.00346	0.00368	CcSEcCtD
Sotalol—Nausea—Vinblastine—head and neck cancer	0.00345	0.00367	CcSEcCtD
Sotalol—Insomnia—Fluorouracil—head and neck cancer	0.00344	0.00367	CcSEcCtD
Sotalol—Paraesthesia—Fluorouracil—head and neck cancer	0.00342	0.00364	CcSEcCtD
Sotalol—Alopecia—Docetaxel—head and neck cancer	0.00342	0.00364	CcSEcCtD
Sotalol—Dyspnoea—Fluorouracil—head and neck cancer	0.0034	0.00361	CcSEcCtD
Sotalol—Somnolence—Fluorouracil—head and neck cancer	0.00339	0.0036	CcSEcCtD
Sotalol—Vomiting—Hydroxyurea—head and neck cancer	0.00336	0.00358	CcSEcCtD
Sotalol—Dyspepsia—Fluorouracil—head and neck cancer	0.00335	0.00357	CcSEcCtD
Sotalol—Rash—Hydroxyurea—head and neck cancer	0.00334	0.00355	CcSEcCtD
Sotalol—Dermatitis—Hydroxyurea—head and neck cancer	0.00333	0.00355	CcSEcCtD
Sotalol—Headache—Hydroxyurea—head and neck cancer	0.00331	0.00353	CcSEcCtD
Sotalol—Decreased appetite—Fluorouracil—head and neck cancer	0.00331	0.00352	CcSEcCtD
Sotalol—Dysgeusia—Docetaxel—head and neck cancer	0.0033	0.00351	CcSEcCtD
Sotalol—Back pain—Docetaxel—head and neck cancer	0.00326	0.00347	CcSEcCtD
Sotalol—Pain—Fluorouracil—head and neck cancer	0.00326	0.00347	CcSEcCtD
Sotalol—Muscle spasms—Docetaxel—head and neck cancer	0.00324	0.00345	CcSEcCtD
Sotalol—Nausea—Hydroxyurea—head and neck cancer	0.00314	0.00335	CcSEcCtD
Sotalol—Syncope—Docetaxel—head and neck cancer	0.00302	0.00322	CcSEcCtD
Sotalol—Leukopenia—Docetaxel—head and neck cancer	0.00302	0.00321	CcSEcCtD
Sotalol—Body temperature increased—Fluorouracil—head and neck cancer	0.00301	0.0032	CcSEcCtD
Sotalol—Palpitations—Docetaxel—head and neck cancer	0.00298	0.00317	CcSEcCtD
Sotalol—Loss of consciousness—Docetaxel—head and neck cancer	0.00296	0.00315	CcSEcCtD
Sotalol—Cough—Docetaxel—head and neck cancer	0.00294	0.00313	CcSEcCtD
Sotalol—Hypertension—Docetaxel—head and neck cancer	0.00291	0.0031	CcSEcCtD
Sotalol—Chest pain—Docetaxel—head and neck cancer	0.00287	0.00305	CcSEcCtD
Sotalol—Myalgia—Docetaxel—head and neck cancer	0.00287	0.00305	CcSEcCtD
Sotalol—Oedema—Docetaxel—head and neck cancer	0.00275	0.00293	CcSEcCtD
Sotalol—Infection—Docetaxel—head and neck cancer	0.00273	0.00291	CcSEcCtD
Sotalol—Shock—Docetaxel—head and neck cancer	0.0027	0.00288	CcSEcCtD
Sotalol—Pruritus—Fluorouracil—head and neck cancer	0.00269	0.00287	CcSEcCtD
Sotalol—Thrombocytopenia—Docetaxel—head and neck cancer	0.00269	0.00287	CcSEcCtD
Sotalol—Diarrhoea—Fluorouracil—head and neck cancer	0.00261	0.00277	CcSEcCtD
Sotalol—Hypotension—Docetaxel—head and neck cancer	0.00257	0.00273	CcSEcCtD
Sotalol—Dizziness—Fluorouracil—head and neck cancer	0.00252	0.00268	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.0025	0.00267	CcSEcCtD
Sotalol—Insomnia—Docetaxel—head and neck cancer	0.00249	0.00265	CcSEcCtD
Sotalol—Paraesthesia—Docetaxel—head and neck cancer	0.00247	0.00263	CcSEcCtD
Sotalol—Dyspnoea—Docetaxel—head and neck cancer	0.00245	0.00261	CcSEcCtD
Sotalol—Somnolence—Docetaxel—head and neck cancer	0.00244	0.0026	CcSEcCtD
Sotalol—Vomiting—Fluorouracil—head and neck cancer	0.00242	0.00258	CcSEcCtD
Sotalol—Dyspepsia—Docetaxel—head and neck cancer	0.00242	0.00258	CcSEcCtD
Sotalol—Rash—Fluorouracil—head and neck cancer	0.0024	0.00256	CcSEcCtD
Sotalol—Dermatitis—Fluorouracil—head and neck cancer	0.0024	0.00255	CcSEcCtD
Sotalol—Decreased appetite—Docetaxel—head and neck cancer	0.00239	0.00254	CcSEcCtD
Sotalol—Headache—Fluorouracil—head and neck cancer	0.00239	0.00254	CcSEcCtD
Sotalol—Fatigue—Docetaxel—head and neck cancer	0.00237	0.00252	CcSEcCtD
Sotalol—Pain—Docetaxel—head and neck cancer	0.00235	0.0025	CcSEcCtD
Sotalol—Nausea—Fluorouracil—head and neck cancer	0.00226	0.00241	CcSEcCtD
Sotalol—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00225	0.00239	CcSEcCtD
Sotalol—Abdominal pain—Docetaxel—head and neck cancer	0.00217	0.00231	CcSEcCtD
Sotalol—Body temperature increased—Docetaxel—head and neck cancer	0.00217	0.00231	CcSEcCtD
Sotalol—Asthenia—Docetaxel—head and neck cancer	0.00197	0.0021	CcSEcCtD
Sotalol—Pruritus—Docetaxel—head and neck cancer	0.00194	0.00207	CcSEcCtD
Sotalol—Diarrhoea—Docetaxel—head and neck cancer	0.00188	0.002	CcSEcCtD
Sotalol—Dizziness—Docetaxel—head and neck cancer	0.00182	0.00194	CcSEcCtD
Sotalol—Vomiting—Docetaxel—head and neck cancer	0.00175	0.00186	CcSEcCtD
Sotalol—Rash—Docetaxel—head and neck cancer	0.00173	0.00184	CcSEcCtD
Sotalol—Dermatitis—Docetaxel—head and neck cancer	0.00173	0.00184	CcSEcCtD
Sotalol—Headache—Docetaxel—head and neck cancer	0.00172	0.00183	CcSEcCtD
Sotalol—Nausea—Docetaxel—head and neck cancer	0.00163	0.00174	CcSEcCtD
